Publications

Brat DJ, Aldape K, Colman H, Figrarella-Branger D, Fuller GN, Giannini C, Holland EC, Jenkins RB, Kleinschmidt-DeMasters B, Komori T, Kros JM, Louis DN, McLean C, Perry A, Reifenberger G, Sarkar C, Stupp R, van den Bent MJ, von Deimling A, Weller M.Brat DJ, et al. cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. Acta Neuropathol. 2020 Mar; 139 (3):603-608. doi: 10.1007/s00401-020-02127-9. Epub 2020 Jan 29. Acta Neuropathol. 2020. PMID: 31996992.

Kan LK, Drummond KJ, Hunn MK, Williams DA, O'Brien TJ, Monif M. A Simple and Reliable Protocol for the Preparation and Culturing of Fresh Surgically Resected Human Glioblastoma Tissue. Methods Protoc. 2020 Jan; 3(1):11. doi:10.3390/mps3010011

Kan LK, Seveviratne S, Drummond KJ, Williams DA, O’Brien TJ, Monif M. P2X7 receptor antagonism inhibits tumour grown in human high-grade gliomas. Purinergic Signalling. 2020. https://doi.org/10.1007/s11302-020-09705-2

Kan LK, Williams DA, Kate Drummond KL, O'Brien TJ, Monif M. The role of microglia and P2X7 receptors in gliomas. Journal of Neuroimmunology. 2019; 332.138-146. doi: 10.1016/j.jneuroim.2019.04.010.

Louis DN, Wesseling P, Brandner S, Brat DJ, Ellison DW, Giangaspero F, Hattab EM, Hawkins C, Judge MJ, Kleinschmidt-DeMasters B., et al. Data Sets for the Reporting of Tumors of the Central Nervous System. Arch Pathol Lab Med. 2019. DOI: 10.5858/arpa.2018-0565-OA 

Ong WL, Kang TMJ, Ratnayake G, Wada M, Ruben J, Senthi S, Milne RL, Millar JL, Foroudi F. Stereotactic radiosurgery for managing brain metastases in Victoria, 2012-2017. Medical Journal of Australia. 2020. https://doi.org/10.5694/mja2.50573

Ong WL, Wada M, Ruben J, Foroudi F, Millar J. Contemporary practice patterns of stereotactic radiosurgery for brain metastasis: A review of published Australian literature. Journal of Medical Imaging and Radiation Oncology. 2019; 63(5). 711-720. doi.org/10.1111/1754-9485.12942

Ratnayake G, Oh T, Mehta R, Hardy T, Woodford K, Haward R, Ruben JD, Dally MJ. Long-term treatment outcomes of patients with primary optic nerve sheath meningioma treated with stereotactic radiotherapy. Journal of Clinical Neuroscience. 2019; 68. 162-167. https://doi.org/10.1016/j.jocn.2019.07.005

Raza IJ , Tingate CA, Gkolia P,  Romero L, Tee JW, Hunn, MK. Blood biomarkers of glioma in response assessment including pseudoprogression and other treatment effects: a systematic review. Front. Oncol. 2020. doi: 10.3389/fonc.2020.01191 (**abstract published waiting for full text publication)

Van den Bent MJ, Baumert B, Errifge SC, Vogelbaum MA, Nowak AK, Sanson M, Brandes AA, Clement, PM, Baurain JF, Mason WP, Wheeler H, Chinot OL, Gill S, Griffin M, Brachman DG, Taal W, Rudà R, Weller M, McBain C, Reijneveld J, Enting RH, Weber DC, Lesimple T, Clenton S, Gijtenbeek A, Pascoe S, Herrlinger U, Hau P, Dhermain F, Heuvel IV, Stupp R, Aldape K, Jenkins RB, Dubbink HJ, Dinjens WNM, Wesseling P, Nuyens S, Golfinopoulos V, Gorlia T, Wick W, Kros JM. 2nd interim analysis and IDH status of the EORTC CATNON trial, on adjuvant and concurrent temozolomide in anaplastic astrocytoma. (**submitted to Lancet for publication in 2020.)